Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Construction in Progress: 2023-2024

  • Zhengye Biotechnology Holding's Construction in Progress rose 26.30% to $1.3 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.3 million, marking a year-over-year increase of 26.30%. This contributed to the annual value of $1.3 million for FY2024, which is 23.97% up from last year.
  • As of Q4 2024, Zhengye Biotechnology Holding's Construction in Progress stood at $1.3 million, which was up 26.30% from $1.1 million recorded in Q4 2023.
  • Zhengye Biotechnology Holding's Construction in Progress' 5-year high stood at $1.3 million during Q4 2024, with a 5-year trough of $1.1 million in Q4 2023.
  • In the last 2 years, Zhengye Biotechnology Holding's Construction in Progress had a median value of $1.2 million in 2023 and averaged $1.2 million.
  • Data for Zhengye Biotechnology Holding's Construction in Progress shows a peak YoY climbed of 26.30% (in 2024) over the last 5 years.
  • Over the past 2 years, Zhengye Biotechnology Holding's Construction in Progress (Quarterly) stood at $1.1 million in 2023, then grew by 26.30% to $1.3 million in 2024.